Lexaria Bioscience (LEXX) Operating Margin (2017 - 2026)
Lexaria Bioscience's Operating Margin was -7259.52% in fiscal Q2 2026 (quarter ended Feb 28, 2026), down 5678.47 percentage points from -1581.04% a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Operating Margin (2017 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Operating Margin at Lexaria Bioscience came in at -1683.01%, down 443.85 percentage points from FY2024.
- Operating Margin shows a five-year change of -365.06 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Operating Margin was -1239.16% in FY2024 (+1649.35 pp), -2888.50% in FY2023 (-296.84 pp), -2591.67% in FY2022 (-1804.82 pp) and -786.85% in FY2021 (+531.10 pp).
- The fiscal Q2 2026 figure marks the lowest quarterly Operating Margin since fiscal Q1 2022.
- Compared with a year earlier, Operating Margin was higher in three of the last seven quarters, with an average year-over-year change of -642.22 percentage points.
- The best year-over-year quarter for Operating Margin over five years was fiscal Q1 2023 (a gain of 12699.60 percentage points); the worst was fiscal Q1 2022 (a drop of 14193.11 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 28.37% |
| 10 | Lexaria Bioscience | 2.60 Mn | -12.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | -7,259.52% |
| Aug 31, 2025 | -1,545.17% |
| May 31, 2025 | -2,155.41% |
| Feb 28, 2025 | -1,581.04% |
| Nov 30, 2024 | -1,462.95% |
| Aug 31, 2024 | -2,622.70% |
| May 31, 2024 | -2,074.90% |
| Feb 29, 2024 | -460.69% |
| Nov 30, 2023 | -753.01% |
| Aug 31, 2023 | -3,624.19% |
| May 31, 2023 | -3,089.64% |
| Feb 28, 2023 | -6,609.86% |
| Nov 30, 2022 | -1,734.71% |
| Aug 31, 2022 | -673.46% |
| May 31, 2022 | -2,425.20% |
| Feb 28, 2022 | -4,726.50% |
| Nov 30, 2021 | -14,434.31% |
| Aug 31, 2021 | -4,199.30% |
| May 31, 2021 | -1,257.77% |
| Feb 28, 2021 | -575.25% |
API Access
Lexaria Bioscience Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();